SEC Info - NovaBay Pharmaceuticals, Inc. - ‘10-Q’ for 6/30/10

SEC Info℠

Home

Help

Please Sign In

NovaBay Pharmaceuticals, Inc. – ‘10-Q’ for 6/30/10 – EX-32.2

On: Thursday, 8/12/10, at 8:51am ET · For: 6/30/10 · Accession #: 1437749-10-2592 · File #: 1-33678

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/12/10  NovaBay Pharmaceuticals, Inc.     10-Q        6/30/10    6:978K                                   RDG Filings/FA

Quarterly Report — Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    503K 
 2: EX-10.1     Material Contract                                   HTML     65K 
 3: EX-31.1     Certification per Sarbanes-Oxley Act (Section 302)  HTML     12K 
 4: EX-31.2     Certification per Sarbanes-Oxley Act (Section 302)  HTML     12K 
 5: EX-32.1     Certification per Sarbanes-Oxley Act (Section 906)  HTML      8K 
 6: EX-32.2     Certification per Sarbanes-Oxley Act (Section 906)  HTML      8K

EX-32.2 — Certification per Sarbanes-Oxley Act (Section 906)

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NovaBay Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas J. Paulson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 11, 2010

/s/ Thomas J. Paulson

Thomas J. Paulson

Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-Q’ Filing	Date	Other Filings

Filed on:	8/12/10
	8/11/10
For Period End:	6/30/10	S-8 POS
		List all Filings

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/04/22  NovaBay Pharmaceuticals, Inc.     S-1                    5:953K                                   RDG Filings/FA
12/01/21  NovaBay Pharmaceuticals, Inc.     S-1                   15:1.1M                                   RDG Filings/FA
 3/25/21  NovaBay Pharmaceuticals, Inc.     10-K       12/31/20  101:10M                                    RDG Filings/FA
11/12/20  NovaBay Pharmaceuticals, Inc.     10-Q        9/30/20   89:10M                                    RDG Filings/FA

↑Top

Filing Submission 0001437749-10-002592 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)